LucidScope
AI is already answering questions about your brand. LucidScope shows you what it’s saying, and why.
LucidScope evaluates how leading AI systems respond to real-world questions about your company, products, indications, and competitors.
It maps visibility and positioning in AI-generated answers, traces the sources shaping those answers, and highlights gaps where evidence is missing, outdated, or misrepresented.
What you can do with LucidScope:
-
Perception Mapping: Compare how AI positions your brand versus key competitors.
- See how AI frames your brand versus competitors, by theme and attribute.
-
Answers Mapping: See how models answer the same stakeholder questions, and where they diverge.
- View side-by-side model answers to your key questions, with differences highlighted.
-
Source Tracing: Identify which websites and documents are shaping AI answers, and where to intervene.
- Understand which domains and documents drive the answers, and what’s missing.
-
Launch and campaign monitoring: Track changes over time across models, markets, and topics.
- Monitor shifts in positioning, key claims, and cited sources (you vs competitors).
LucidScope is part of LucidQuest’s intelligence stack, complementing our primary research, conference coverage, and wargaming capabilities.
Combined with NexusBrain (nexusbrain.io), LucidScope insights can be mapped alongside your team’s own field observations to give a complete picture of how AI is shaping your brand’s perception.
Want to see what AI is saying about your brand? Request an AI Answer Audit.
You’ll receive a short report covering Perception, Answers, Source Tracing, and Zero-click gaps.
Already evaluating tools? Test LucidScope.
Questions or feedback? Email us anytime.
July 31, 2026
Respiratory Strategic Roundup | June 25 – July 30, 2026
July 30, 2026
Johnson & Johnson Firefly Bio Acquisition | Lucid Diligence Brief
July 30, 2026
Cell and Gene Therapy Strategic Roundup | June 24–July 29, 2026
July 28, 2026
Massive Bio and GELL Partnership | Lucid Diligence Brief
July 28, 2026
Obesity Strategic Roundup | June 22–July 27, 2026
July 23, 2026
Cardiovascular Strategic Roundup | June 25–July 21, 2026
July 23, 2026
Evogene and ELEO Oral PCSK9 Collaboration | Lucid Diligence Brief
July 22, 2026
Neuroscience Strategic Roundup | June17–July 21, 2026
July 21, 2026
Endocrinology Strategic Roundup | June 23–July 20, 2026
July 20, 2026